Morepen Laboratories consolidated net profit declines 28.15% in the March 2025 quarter

Net profit of Morepen Laboratories declined 28.15% to Rs 20.32 crore in the quarter ended March 2025 as against Rs 28.28 crore during the previous quarter ended March 2024. Sales rose 10.11% to Rs 465.85 crore in the quarter ended March 2025 as against Rs 423.07 crore during the previous quarter ended March 2024.

For the full year,net profit rose 22.73% to Rs 118.02 crore in the year ended March 2025 as against Rs 96.16 crore during the previous year ended March 2024. Sales rose 7.17% to Rs 1811.58 crore in the year ended March 2025 as against Rs 1690.43 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	465.85	423.07	10	1811.58	1690.43	7
OPM %	9.07	11.44	-	9.61	9.38	-
PBDT	42.18	51.83	-19	184.09	168.89	9
PBT	25.71	42.20	-39	155.11	135.42	15
NP	20.32	28.28	-28	118.02	96.16	23